Hirotsugu Hasegawa

Hamamatsu, 4338558, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trial.

Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trial.

Journal: Respiratory medicine and research
Published: February 20, 2025

Severe bronchiectasis and chronic rhinosinusitis due to homozygous WFDC2 Variants: The first three cases reported from Japan.

Severe bronchiectasis and chronic rhinosinusitis due to homozygous WFDC2 Variants: The first three cases reported from Japan.

Journal: Respiratory medicine case reports
Published: February 17, 2025

Hypnotics and Mortality in Idiopathic Pulmonary Fibrosis: Hospital and National Data-Based Analysis.

Hypnotics and Mortality in Idiopathic Pulmonary Fibrosis: Hospital and National Data-Based Analysis.

Journal: Chest
Published: March 30, 2024

Prognostic value of computed tomography assessment of normal lung volume in upper lobe in idiopathic pleuroparenchymal fibroelastosis.

Prognostic value of computed tomography assessment of normal lung volume in upper lobe in idiopathic pleuroparenchymal fibroelastosis.

Journal: ERJ open research
Published: December 18, 2023

Neutrophil-lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy.

Neutrophil-lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy.

Journal: Respiratory medicine
Published: October 02, 2023

Neutrophil-lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis.

Neutrophil-lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis.

Journal: BMJ open respiratory research
Published: April 13, 2023

Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis.

Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis.

Journal: ERJ open research
Published: December 27, 2022

Standardized 3D-CT lung volumes for patients with acute exacerbation of rheumatoid arthritis-associated interstitial lung disease.

Standardized 3D-CT lung volumes for patients with acute exacerbation of rheumatoid arthritis-associated interstitial lung disease.

Journal: Rheumatology (Oxford, England)
Published: December 19, 2022

Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial.

Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial.

Journal: Thorax
Published: October 28, 2022

Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis.

Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis.

Journal: Respirology (Carlton, Vic.)
Published: October 11, 2022

Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.

Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.

Journal: Therapeutic advances in chronic disease
Published: January 25, 2022

Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volume.

Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volume.

Journal: The European respiratory journal
Published: December 20, 2021
Showing 1-12 of 34

Last Updated: 09/26/2026